Your browser doesn't support javascript.
loading
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.
López de Maturana, Evangelina; Rodríguez, Juan Antonio; Alonso, Lola; Lao, Oscar; Molina-Montes, Esther; Martín-Antoniano, Isabel Adoración; Gómez-Rubio, Paulina; Lawlor, Rita; Carrato, Alfredo; Hidalgo, Manuel; Iglesias, Mar; Molero, Xavier; Löhr, Matthias; Michalski, Christopher; Perea, José; O'Rorke, Michael; Barberà, Victor Manuel; Tardón, Adonina; Farré, Antoni; Muñoz-Bellvís, Luís; Crnogorac-Jurcevic, Tanja; Domínguez-Muñoz, Enrique; Gress, Thomas; Greenhalf, William; Sharp, Linda; Arnes, Luís; Cecchini, Lluís; Balsells, Joaquim; Costello, Eithne; Ilzarbe, Lucas; Kleeff, Jörg; Kong, Bo; Márquez, Mirari; Mora, Josefina; O'Driscoll, Damian; Scarpa, Aldo; Ye, Weimin; Yu, Jingru; García-Closas, Montserrat; Kogevinas, Manolis; Rothman, Nathaniel; Silverman, Debra T; Albanes, Demetrius; Arslan, Alan A; Beane-Freeman, Laura; Bracci, Paige M; Brennan, Paul; Bueno-de-Mesquita, Bas; Buring, Julie; Canzian, Federico.
Afiliación
  • López de Maturana E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.
  • Rodríguez JA; CIBERONC, Madrid, Spain.
  • Alonso L; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Lao O; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.
  • Molina-Montes E; CIBERONC, Madrid, Spain.
  • Martín-Antoniano IA; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Gómez-Rubio P; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.
  • Lawlor R; CIBERONC, Madrid, Spain.
  • Carrato A; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.
  • Hidalgo M; CIBERONC, Madrid, Spain.
  • Iglesias M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.
  • Molero X; CIBERONC, Madrid, Spain.
  • Löhr M; ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
  • Michalski C; CIBERONC, Madrid, Spain.
  • Perea J; Department of Oncology, Ramón y Cajal University Hospital, IRYCIS, Alcala University, Madrid, Spain.
  • O'Rorke M; Madrid-Norte-Sanchinarro Hospital, Madrid, Spain.
  • Barberà VM; Weill Cornell Medicine, New York, USA.
  • Tardón A; CIBERONC, Madrid, Spain.
  • Farré A; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
  • Muñoz-Bellvís L; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Crnogorac-Jurcevic T; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
  • Domínguez-Muñoz E; Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Gress T; Department of Surgery, Technical University of Munich, Munich, Germany.
  • Greenhalf W; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
  • Sharp L; Department of Surgery, Hospital 12 de Octubre, and Department of Surgery and Health Research Institute, Fundación Jiménez Díaz, Madrid, Spain.
  • Arnes L; Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Cecchini L; College of Public Health, The University of Iowa, Iowa City, IA, USA.
  • Balsells J; Molecular Genetics Laboratory, General University Hospital of Elche, Elche, Spain.
  • Costello E; Department of Medicine, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Ilzarbe L; CIBERESP, Madrid, Spain.
  • Kleeff J; Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Kong B; CIBERONC, Madrid, Spain.
  • Márquez M; Department of Surgery, Hospital Universitario de Salamanca - IBSAL, Universidad de Salamanca, Salamanca, Spain.
  • Mora J; Barts Cancer Institute, Centre for Molecular Oncology, Queen Mary University of London, London, UK.
  • O'Driscoll D; Department of Gastroenterology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
  • Scarpa A; Department of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany.
  • Ye W; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Yu J; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
  • García-Closas M; Centre for Stem Cell Research and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.
  • Kogevinas M; Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA.
  • Rothman N; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.
  • Silverman DT; CIBERONC, Madrid, Spain.
  • Albanes D; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Arslan AA; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
  • Beane-Freeman L; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Bracci PM; CIBERONC, Madrid, Spain.
  • Brennan P; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
  • Bueno-de-Mesquita B; Department of Surgery, Technical University of Munich, Munich, Germany.
  • Buring J; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
  • Canzian F; Department of Surgery, Technical University of Munich, Munich, Germany.
Genome Med ; 13(1): 15, 2021 02 01.
Article en En | MEDLINE | ID: mdl-33517887
ABSTRACT

BACKGROUND:

Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance.

METHODS:

We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants.

RESULTS:

We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E-06 in 1D approach and a Local Moran's Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8-a lncRNA associated with pancreatic carcinogenesis-with a lowest p value = 6.91E-05. Importantly, two new PC loci were identified both by 2D and 3D approaches SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1-a major regulator of the ER stress and unfolded protein responses in acinar cells-identified by 3D; all of them with a strong in silico functional support.

CONCLUSIONS:

This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Predisposición Genética a la Enfermedad / Estudio de Asociación del Genoma Completo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Predisposición Genética a la Enfermedad / Estudio de Asociación del Genoma Completo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: España